Journal article · 2026 · Open access

Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol

Huijun Wang, Ziyao Kang, Xiaoshuang Wang, Zheng Pan, Yun Sun, Yuan Li, Xin Li, Shuai Shao, Xiang Zheng, Zibo Han, Jin Ren

International Journal of Pharmaceutics X, 11, 100553 · Published 1 May 2026 · DOI 10.1016/j.ijpx.2026.100553

Open full textCite this paper

In brief

“Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol” is a 2026 journal article by Huijun Wang and 10 co-authors, published in International Journal of Pharmaceutics X. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at International Journal of Pharmaceutics X.

Citations
0
References
45
Authors
11

Abstract

The widespread application of lipid nanoparticles (LNPs) as mRNA delivery vectors is constrained by the intrinsic trade-off between delivery efficacy and inflammatory reactogenicity. To address this limitation, we engineered a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α- tocopherol (TP). Capitalizing on its well-documented anti-inflammatory and immunomodulatory properties, we hypothesized that incorporating TP or its derivatives into LNPs would concurrently mitigate carrier-induced inflammation and enhance antigen-specific immunogenicity. Our results demonstrated that TP succinate (TPS)-modified LNPs significantly improved in vitro mRNA delivery, achieving up to a 9.5-fold increase in protein expression alongside enhanced cellular uptake, without compromising biocompatibility. Following immunization, TPS-LNPs markedly reduced acute inflammatory reactogenicity, as evidenced by a threefold lower serum IL-6 level at 6 h compared to the standard formulation in blank-LNP groups, and by significantly attenuated cytokine levels in mRNA-loaded groups. In vivo , TPS-LNPs elicited robust and balanced immune responses, characterized by potent humoral immunity and enhanced antigen-specific T cell activation. Mechanistically, the enhanced immunogenicity was associated with upregulated CD40 expression on antigen-presenting cells. Importantly, the anti-inflammatory attributes of TP derivatives conferred an excellent safety profile, with no evidence of significant tissue damage or systemic toxicity. Our findings advocate for a functionalization paradigm in LNP design, wherein α -tocopherol derivatives serve as intrinsic modulators to recalibrate innate immunity, thereby proposing a new design benchmark for simultaneously safe and potent mRNA delivery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, H., Kang, Z., Wang, X., Pan, Z., Sun, Y., Li, Y., Li, X., Shao, S., Zheng, X., Han, Z., & Ren, J. (2026). Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol. International Journal of Pharmaceutics X, 11, 100553. https://doi.org/10.1016/j.ijpx.2026.100553

MLA 9

Wang, Huijun, et al. “Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol.” International Journal of Pharmaceutics X, vol. 11, 2026, p. 100553. https://doi.org/10.1016/j.ijpx.2026.100553.

Chicago

Wang, Huijun, Ziyao Kang, Xiaoshuang Wang, Zheng Pan, Yun Sun, Yuan Li, Xin Li, et al. 2026. “Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol.” International Journal of Pharmaceutics X 11: 100553. https://doi.org/10.1016/j.ijpx.2026.100553.

Harvard

Wang, H. et al. (2026) ‘Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol’, International Journal of Pharmaceutics X, 11, p. 100553. doi:10.1016/j.ijpx.2026.100553.

IEEE

H. Wang et al., “Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol,” International Journal of Pharmaceutics X, vol. 11, p. 100553, 2026, doi: 10.1016/j.ijpx.2026.100553.

BibTeX

@article{wang2026engineering,
  title     = {{Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol}},
  author    = {Wang, Huijun and Kang, Ziyao and Wang, Xiaoshuang and Pan, Zheng and Sun, Yun and Li, Yuan and Li, Xin and Shao, Shuai and Zheng, Xiang and Han, Zibo and Ren, Jin},
  journal   = {International Journal of Pharmaceutics X},
  year      = {2026},
  volume    = {11},
  pages     = {100553},
  doi       = {10.1016/j.ijpx.2026.100553},
  url       = {https://doi.org/10.1016/j.ijpx.2026.100553}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • alpha-tocopherol
  • tocopherol succinate
  • immunogenicity
  • interleukin-6
  • CD40
  • antigen-presenting cells

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Wang, H., Kang, Z., Wang, X., Pan, Z., Sun, Y., Li, Y., Li, X., Shao, S., Zheng, X., Han, Z., & Ren, J. (2026). Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol. International Journal of Pharmaceutics X, 11, 100553. https://doi.org/10.1016/j.ijpx.2026.100553

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Pharmaceutics X: sign in and open the full text from this page.

Who wrote this paper?

Huijun Wang, Ziyao Kang, Xiaoshuang Wang, Zheng Pan, Yun Sun, Yuan Li, Xin Li, Shuai Shao, Xiang Zheng, Zibo Han, Jin Ren.

What is the DOI of this paper?

10.1016/j.ijpx.2026.100553, permanently at https://doi.org/10.1016/j.ijpx.2026.100553. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.